Surgery Doctors in Carolina, PR Accepting Medicare

6 Surgery doctors found. Showing 1 - 6

Dr. Viviana Maria Negron-gonzalez, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Hospital De La Upr Dr. Federico Trilla, Ave. 65 De Infanteria Carr 3 Km 8.3, Carolina, PR 00984 Phone: 787-757-1800    Fax: 787-757-0520

Dr. Luciano Puccio Hernandez, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Ave. 65 Infantery, Carr. #3 Km 8.3, Carolina, PR 00984 Phone: 787-757-1800

Dr. Carlos A Morales Ruiz, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: A6 Ave. Campo Rico, Castellana Gardens, Carolina, PR 00983 Phone: 787-752-7897

William Titley Diaz, MD Surgery Medicare: Medicare Enrolled Practice Location: Hospital Upr Federico Trilla Ave 65 Infanteria, Primer Piso Area Administrativa, Carolina, PR 00984 Phone: 787-769-4520

Mauro Iranzo, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Upr Hospital-65th Infanteria Ave., 3rd Floor-dpt. Of Surgery, Carolina, PR 00984 Phone: 787-757-1800

Armando Javier Cruzado, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Mansiones Vistamar Marina, 1420 Marbella Street, Carolina, PR 00983 Phone: 787-762-3047

News Archive

Highmark to deploy PatientPoint self-service check-in technology to Western Pennsylvania providers

PatientPoint™, a provider of self-service and revenue cycle management applications, today announced a partnership with Highmark Inc., an independent licensee of the Blue Cross and Blue Shield Association based in Pittsburgh. Through its partnership, Highmark will deploy PatientPoint self-service check-in technology to select providers in its Western Pennsylvania market.

Scientists discover mechanism that could offer potential new solution to tooth repair

Stem cells hold the key for tissue engineering, as they develop into specialized cell types throughout the body including in teeth.

FDA designates Synageva's sebelipase alfa as Breakthrough Therapy for early onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today announced that the U.S. Food and Drug Administration granted Breakthrough Therapy designation to sebelipase alfa for the treatment of early onset lysosomal acid lipase deficiency, also known as Wolman disease.

Children exposed to natural playgrounds tend to be more active

Children who play on playgrounds that incorporate natural elements like logs and flowers tend to be more active than those who play on traditional playgrounds with metal and brightly colored equipment, according to a recent study from the University of Tennessee, Knoxville.

Intra-arterial therapy no more effective than IV t-PA in treating acute ischemic stroke

A stroke survivor's chances of living independently after 90 days are not improved by the use of devices inserted into the artery to dissolve or remove a stroke-causing clot shortly after the onset of symptoms, according to a randomized controlled trial involving 656 patients.

Read more Medical News

› Verified 9 days ago